Literature DB >> 3744471

Norepinephrine removal and release in the forearm of healthy subjects.

P C Chang, J A van der Krogt, P Vermeij, P van Brummelen.   

Abstract

The relevance of local removal and release of norepinephrine (NE) for antecubital venous plasma NE concentration was studied in 22 healthy subjects. Arterial and venous plasma NE and forearm blood flow were measured during intra-arterial infusion of two doses of NE, intra-arterial NE infusion with two doses of sodium nitroprusside, intravenous infusion of NE with intra-arterial infusion of four doses of sodium nitroprusside, and lower body negative pressure of -20 mm Hg for 15 minutes. The venous plasma NE concentration-time curves during the infusions of the two doses of NE indicated first-order kinetics for forearm extraction: forearm NE extraction rate during the low dose infusion was 67 +/- 4.1% (SEM) and correlated with basal forearm blood flow (r = -0.64, p less than 0.03, n = 12). Local sodium nitroprusside-induced vasodilatation during the intra-arterial and intravenous NE infusions was accompanied by dose-dependent decreases in forearm extraction rates for NE and epinephrine. During lower body negative pressure, taking into account the high basal forearm extraction rate for NE, local and systemic release of NE was indicated by increases in arterial and venous plasma and the venous-arterial plasma NE concentration difference (p less than 0.05 for all). These data show that removal of NE from forearm circulation is a process with a high extraction ratio obeying first-order kinetics and that this extraction process inversely relates to forearm blood flow. Thus, antecubital venous plasma NE is likely to be derived mainly from local release and not from the arterial plasma NE input.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3744471     DOI: 10.1161/01.hyp.8.9.801

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.

Authors:  E Paran; L Neumann; N Cristal
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.

Authors:  J van Harten; J Burggraaf; P van Brummelen; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man.

Authors:  G J Blauw; R G Westendorp; M Simons; P C Chang; M Frölich; A E Meinders
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

Review 4.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

5.  Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension.

Authors:  Sachin S Kandlikar; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

6.  Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.

Authors:  Igor Elman; David Rott; Alan I Green; Daniel D Langleben; Scott E Lukas; David S Goldstein; Alan Breier
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

7.  Relationship between arterial and peripheral venous catecholamine plasma catecholamine concentrations during infusion of noradrenaline and adrenaline in healthy volunteers.

Authors:  H Ensinger; T Weichel; K H Lindner; A Prengel; A Grünert; F W Ahnefeld
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.

Authors:  B Clemson; L Gaul; S S Gubin; D M Campsey; J McConville; J Nussberger; R Zelis
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.

Authors:  M Beaulieu; A Nadeau; Y Lacourcière; J Cléroux
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.